
TY  - JOUR
TI  - Abstracts
JO  - Epilepsia
JA  - Epilepsia
VL  - 58
IS  - S5
SN  - 0013-9580
UR  - https://doi.org/10.1111/epi.13944
DO  - doi:10.1111/epi.13944
SP  - S5
EP  - S199
PY  - 2017
ER  - 

TY  - JOUR
TI  - Poster Sessions Monday/Tuesday
JO  - Journal of Neurochemistry
JA  - J. Neurochem.
VL  - 150
IS  - S1
SN  - 0022-3042
UR  - https://doi.org/10.1111/jnc.14776
DO  - doi:10.1111/jnc.14776
SP  - 73
EP  - 161
PY  - 2019
ER  - 

TY  - JOUR
TI  - Neurology and neurobiology
JO  - European Journal of Clinical Investigation
VL  - 35
IS  - s2
SN  - 0014-2972
UR  - https://doi.org/10.1111/j.1365-2362.2005.1478_8.x
DO  - doi:10.1111/j.1365-2362.2005.1478_8.x
SP  - A100
EP  - A105
PY  - 2005
ER  - 

TY  - JOUR
AU  - Myrick, Hugh
AU  - Brady, Kathleen T.
AU  - Malcolm, Robert
TI  - New Developments in the Pharmacotherapy of Alcohol Dependence
JO  - The American Journal on Addictions
VL  - 10
IS  - s1
SN  - 1055-0496
UR  - https://doi.org/10.1080/10550490150504092
DO  - doi:10.1080/10550490150504092
SP  - s3
EP  - s15
PY  - 2001
AB  - Neuroscientific underpinnings and pharmacotherapeutic treatments of sub-stance use disorders are rapidly developing areas of study. In particular, there have been exciting new developments in our understanding of the involvement of excitatory amino acid neurotransmitter systems and the opiate and serotonin systems in the pathophysiology of alcohol withdrawal, alcohol dependence, and in subtypes of individuals with alcoholism. In this article, new developments in the pharmacotherapy of alcohol dependence will be reviewed. In particular, the use of anticonvulsants in alcohol withdrawal and protracted abstinence syndromes will be discussed. New data on opiate antagonists and acamprosate, an agent that exerts actions through excitatory amino acid systems in relapse prevention, will be reviewed. Finally, there will be a review of new data concerning the use of serotonin reuptake inhibitors in subtypes of alcoholism and the use of combination pharmacotherapy.
ER  - 

TY  - JOUR
TI  - Poster session 2: (#89 – 174)
JO  - Annals of Neurology
JA  - Ann Neurol.
VL  - 64
IS  - S12
SN  - 0364-5134
UR  - https://doi.org/10.1002/ana.21520
DO  - doi:10.1002/ana.21520
SP  - S114
EP  - S139
PY  - 2008
ER  - 

TY  - JOUR
TI  - Cardiovascular medicine
JO  - European Journal of Clinical Investigation
VL  - 35
IS  - s2
SN  - 0014-2972
UR  - https://doi.org/10.1111/j.1365-2362.2005.1478_1.x
DO  - doi:10.1111/j.1365-2362.2005.1478_1.x
SP  - A1
EP  - A29
PY  - 2005
ER  - 

TY  - JOUR
TI  - Endocrinology, diabetology and metabolism
JO  - European Journal of Clinical Investigation
VL  - 35
IS  - s2
SN  - 0014-2972
UR  - https://doi.org/10.1111/j.1365-2362.2005.1478_2.x
DO  - doi:10.1111/j.1365-2362.2005.1478_2.x
SP  - A30
EP  - A59
PY  - 2005
ER  - 

TY  - JOUR
TI  - Respiratory medicine
JO  - European Journal of Clinical Investigation
VL  - 35
IS  - s2
SN  - 0014-2972
UR  - https://doi.org/10.1111/j.1365-2362.2005.1478_9.x
DO  - doi:10.1111/j.1365-2362.2005.1478_9.x
SP  - A106
EP  - A107
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Bipolar Disorders
VL  - 13
IS  - s1
SN  - 1398-5647
UR  - https://doi.org/10.1111/j.1399-5618.2011.00912.x
DO  - doi:10.1111/j.1399-5618.2011.00912.x
SP  - 27
EP  - 107
PY  - 2011
ER  - 

TY  - JOUR
TI  - Thrombosis and haemostasis
JO  - European Journal of Clinical Investigation
VL  - 35
IS  - s2
SN  - 0014-2972
UR  - https://doi.org/10.1111/j.1365-2362.2005.1478_10.x
DO  - doi:10.1111/j.1365-2362.2005.1478_10.x
SP  - A108
EP  - A114
PY  - 2005
ER  - 

TY  - JOUR
TI  - Gastroenterology and hepatology
JO  - European Journal of Clinical Investigation
VL  - 35
IS  - s2
SN  - 0014-2972
UR  - https://doi.org/10.1111/j.1365-2362.2005.1478_3.x
DO  - doi:10.1111/j.1365-2362.2005.1478_3.x
SP  - A60
EP  - A69
PY  - 2005
ER  - 

TY  - JOUR
AU  - Miao, Pu
AU  - Feng, Jianhua
AU  - Guo, Yufan
AU  - Wang, Jianda
AU  - Xu, Xiaoxiao
AU  - Wang, Ye
AU  - Li, Yanfang
AU  - Gao, Liuyan
AU  - Zheng, Chaoguang
AU  - Cheng, Haiying
TI  - Genotype and phenotype analysis using an epilepsy-associated gene panel in Chinese pediatric epilepsy patients
JO  - Clinical Genetics
JA  - Clin Genet
VL  - 94
IS  - 6
SN  - 0009-9163
UR  - https://doi.org/10.1111/cge.13441
DO  - doi:10.1111/cge.13441
SP  - 512
EP  - 520
KW  - epilepsy
KW  - phenotype
KW  - targeted next-generation sequencing
KW  - treatment
PY  - 2018
AB  - Epilepsy is a common and genetically heterogeneous disorder among children. Advances in next-generation sequencing have revealed that numerous epilepsy genes, helped us improve the understanding of mechanisms underlying epileptogenesis, and guided the development of treatments. We identified 39 candidate variants in 21 genes, including 37 that were pathogenic or likely pathogenic variants according to the American College of Medical Genetics and Genomics scoring system and two variants of uncertain significance that were considered causative after they were associated with clinical characteristics. Thirty were de novo variants (76.9%), and 20 variants had not previously been reported (51.3%). We obtained a diagnosis in 39 of the 141 probands (27.7%). The most frequently mutated gene was SCN1A; KCNQ2, KCNT1, PCDH19, STXBP1, SCN2A, TSC2, and PRRT2 were mutated in more than one individual; ANKRD11, CDKL5, DCX, DEPDC5, GABRB3, GRIN2A, IQSEC2, KCNA2, KCNB1, KCNJ6, TSC1, SCN9A, and SCN1B were mutated in a single individual. In addition, we detected a nonsense variant in a candidate gene KCND1 and considered it as a new candidate epilepsy gene, which needed further functional study. Consequently, large number of unreported variants were detected, diverse phenotypes were associated with known epilepsy genes. Changes in clinical management beyond genetic counseling were suggested.
ER  - 

AU  - Jin, Daqing
AU  - Li, Qiao
AU  - Zhong, Tao P.
C7  - pp. 35-47
TI  - Chemical Genetics in Cardiomyocyte Generation
SN  - 9781118349595
UR  - https://doi.org/10.1002/9781118695746.ch3
DO  - doi:10.1002/9781118695746.ch3
SP  - 35-47
KW  - cardiomyocyte
KW  - iPSCs
KW  - small molecule
KW  - regeneration
KW  - transdifferentiation
KW  - zebrafish
PY  - 2018
AB  - Summary Induced pluripotent stem cell (iPSC) technology represents a breakthrough and offers new perspectives in terms of generating functional cardiomyocytes. Different combinations of chemical compounds that can replace exogenous factors and enhance reprogramming efficiency have been identified. A profound understanding of heart development has laid the foundation for heart regeneration. Recent advances in heart regeneration indicate that cardiomyocyte regeneration occurs primarily through division of differentiating cardiac cells. High-throughput and high-content small-molecule screening studies, particularly in zebrafish, provide insights into heart development and regeneration and shall be the new frontiers in translating cardiovascular research.
ER  - 

TY  - JOUR
TI  - Teratology Society Poster Sessions Abstracts
JO  - Birth Defects Research Part A: Clinical and Molecular Teratology
JA  - Birth Defects Research Part A: Clinical and Molecular Teratology
VL  - 70
IS  - 5
SN  - 9781118349595
UR  - https://doi.org/10.1002/bdra.20028
DO  - doi:10.1002/bdra.20028
SP  - 287
EP  - 323
PY  - 2004
ER  - 

TY  - JOUR
TI  - ABSTRACTS
JO  - Developmental Medicine & Child Neurology
VL  - 37
IS  - s72
SN  - 9781118349595
UR  - https://doi.org/10.1111/j.1469-8749.1995.tb15024.x
DO  - doi:10.1111/j.1469-8749.1995.tb15024.x
SP  - 1
EP  - 137
PY  - 1995
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Annals of Neurology
JA  - Ann Neurol.
VL  - 22
IS  - 3
SN  - 9781118349595
UR  - https://doi.org/10.1002/ana.410220329
DO  - doi:10.1002/ana.410220329
SP  - 406
EP  - 454
PY  - 1987
ER  - 

TY  - JOUR
TI  - Saturday, December 5, 2009 Poster Session 1 1:00 p.m.-8:00 p.m.
JO  - Epilepsia
VL  - 50
IS  - s11
SN  - 9781118349595
UR  - https://doi.org/10.1111/j.1528-1167.2009.02377_1.x
DO  - doi:10.1111/j.1528-1167.2009.02377_1.x
SP  - 1
EP  - 158
PY  - 2009
ER  - 

TY  - JOUR
TI  - 30th International Epilepsy Congress, Montreal, Canada, 23–27 June, 2013
JO  - Epilepsia
JA  - Epilepsia
VL  - 54
IS  - s3
SN  - 9781118349595
UR  - https://doi.org/10.1111/epi.12229
DO  - doi:10.1111/epi.12229
SP  - 30
EP  - 340
PY  - 2013
ER  - 

TY  - JOUR
TI  - Haematology and oncology
JO  - European Journal of Clinical Investigation
VL  - 35
IS  - s2
SN  - 9781118349595
UR  - https://doi.org/10.1111/j.1365-2362.2005.1478_4.x
DO  - doi:10.1111/j.1365-2362.2005.1478_4.x
SP  - A70
EP  - A78
PY  - 2005
ER  - 

TY  - JOUR
TI  - Lipids
JO  - European Journal of Clinical Investigation
VL  - 35
IS  - s2
SN  - 9781118349595
UR  - https://doi.org/10.1111/j.1365-2362.2005.1478_6.x
DO  - doi:10.1111/j.1365-2362.2005.1478_6.x
SP  - A88
EP  - A92
PY  - 2005
ER  - 
